Wird geladen...
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions
BACKGROUND AND PURPOSE: Telmisartan suppresses the development of endometriotic lesions. However, the drug also up‐regulates the expression of COX‐2, which has been suggested to promote the progression of endometriosis. Accordingly, in the present study we analysed whether a combination therapy with...
Gespeichert in:
| Veröffentlicht in: | Br J Pharmacol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522992/ https://ncbi.nlm.nih.gov/pubmed/28548231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13874 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|